Pre‐treatment average of apparent diffusion coefficient minimum calculation by histogram analysis is a predictive imaging biomarker for overall survival in patients with recurrent glioblastoma treated with anti‐VEGF monotherapy at first or second relapse.16 These methods may give valuable information, however, these methods themselves are complicated and not suitable for generalization. This evidence concerns the gene VEGFA and glioblastoma.